Stock has completed its Correction phase and found its lowest at 860, much below the 1700 IPO listing.
Stock seems to be forming a new Higher High and Higher Low Pattern since Oct 2023.
Also it can be seen following the Trendline as well.
A Hammer on the weekly close last week, could indicate a strong support forming exactly on the Trendline, which is a good sign for further upward move.
If all goes right, the stock could make it to its next leg up.
Stoploss mentioned is crucial. If broken, the stock could start seeing further lows.
Stock seems to be forming a new Higher High and Higher Low Pattern since Oct 2023.
Also it can be seen following the Trendline as well.
A Hammer on the weekly close last week, could indicate a strong support forming exactly on the Trendline, which is a good sign for further upward move.
If all goes right, the stock could make it to its next leg up.
Stoploss mentioned is crucial. If broken, the stock could start seeing further lows.
노트
News:Fosun Is Said To Plan Block Deals To Pare 6% Stake In Gland Pharma - Bloomberg News
액티브 트레이드
Trade back at our Entry Zone.노트
What a Price movement today. Almost did 80% of our Target in just a single candle. 노트
14% Profits done so far. Trade seems to be going exactly as expected.
Could hit targets sooner than expected.
Keep a close eye.
노트
Positive News: CO RECEIVES TENTATIVE APPROVAL FROM THE USFDA FOR LATANOPROSTENE BUNOD OPHTHALMIC SOLUTION || SOLTUION HAS US SALES OF APPROXIMATELY USD 153 MILLION노트
Positive News: Q1 CONSOL NET PROFIT 1.44 BILLION RUPEES; IBES PROFIT EST. 2.09 BILLION RUPEES노트
We were so close to our Target Level this week. Just short by 40 points. Hopefully, we will achieve entire target soon.매매 수동청산
Achieved Max Profits of 17%. Unfortunately, the trend has reversed and going downward. Better to exit. Do not hold further. Congrats to those who where able to book up to 17% Profits.
면책사항
해당 정보와 게시물은 금융, 투자, 트레이딩 또는 기타 유형의 조언이나 권장 사항으로 간주되지 않으며, 트레이딩뷰에서 제공하거나 보증하는 것이 아닙니다. 자세한 내용은 이용 약관을 참조하세요.
면책사항
해당 정보와 게시물은 금융, 투자, 트레이딩 또는 기타 유형의 조언이나 권장 사항으로 간주되지 않으며, 트레이딩뷰에서 제공하거나 보증하는 것이 아닙니다. 자세한 내용은 이용 약관을 참조하세요.